Provided by Tiger Trade Technology Pte. Ltd.

Roundhill AMD WeeklyPay ETF

100.42
-1.7662-1.73%
Volume:97.74K
Turnover:9.82M
Market Cap:168.71M
PE:- -
High:102.84
Open:102.77
Low:99.66
Close:102.19
52wk High:115.90
52wk Low:38.30
Shares:1.68M
Float Shares:1.68M
Volume Ratio:1.30
T/O Rate:5.82%
Dividend:49.87
Dividend Rate:49.66%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New Buy Rating for Advanced Micro Devices (AMD), the Technology Giant

TIPRANKS
·
Oct 06

Option traders moderately bearish in Advanced Micro Devices with shares down 0.5%

TIPRANKS
·
Oct 06

AMD Stock Slips After New Ryzen 9 5900X3D CPU Leaks Were Posted in a Chinese Forum

TIPRANKS
·
Oct 06

How OpenFold3 Deployment Will Impact AMD Stock

Simply Wall St.
·
Oct 05

Advanced Micro Devices is Maintained at Buy by Stifel

Dow Jones
·
Oct 05

AMD price target raised to $700 from $635 at Stifel

TIPRANKS
·
Oct 05

Stifel Adjusts Price Target on Advanced Micro Devices to $700 From $635, Keeps Buy Rating

MT Newswires Live
·
Oct 05

Advanced Micro Devices Bets Big on Space and Physical AI

TIPRANKS
·
Oct 03

AMD (AMD) Stock Looks Hard To Value On Cash Flow Alone

Simply Wall St.
·
Oct 03

Micron, Nike, Meta and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

Benzinga Earnings
·
Oct 03

Onsemi Cuts Its Offer By $1.3 Billion — So Why Did Both Stocks Just Jump?

Bellwether Stocks Movement
·
Oct 03

NASDAQ New 52-Week Highs and Lows

Dow Jones
·
Oct 03

Chip Stocks Rally Broadly; Nvidia Rises Nearly 3% to a Record High

Tiger Newspress
·
Oct 02

Three Reasons This Wall Street Market-Making Powerhouse Says Investors Should Reload on Stocks Right Now

Dow Jones
·
Oct 02

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

GlobeNewswire
·
Oct 02

Up 35% In 30 Days: Does AMD Still Have Room To Run After All-Time Highs?

Bellwether Stocks Movement
·
Oct 02

TSMC Studies More U.S. Fabs As AI Chip Demand Strains Capacity

AI Industry Frontlines
·
Oct 02

What You Can Learn From Advanced Micro Devices 263% Gain

Simply Wall St.
·
Oct 02

‘This Changes the Story,’ Says Top Investor About AMD Stock

TIPRANKS
·
Oct 01

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

GlobeNewswire
·
Oct 01